February 2, 2024 – Vizient, Inc. expects drug worth inflation to develop by 3.8% within the newest Pharmacy Market Outlook. Partly pushed by specialty pharmacies, together with the rising use of weight reduction drugs, that is the best anticipated improve since July 2019. Moreover, the anticipated enlargement of gene therapies will additional improve supplier expenditure. View the outlook for the pharmacy market.

Specialty medicine, which deal with costly, complicated or persistent situations equivalent to most cancers, infectious, autoimmune and pulmonary illnesses, make up the vast majority of the highest 15 medicine allotted amongst Vizient pharmacy program individuals. With 42 new specialty medicine authorised in 2023 – and a document variety of approvals possible in 2024 – the anticipated worth improve for specialty medicine is 4.18%.

Weight reduction drugs, gene remedy and biosimilars are largely driving drug worth will increase.

Study extra